Stem Cell Research (Jul 2022)

Generation of isogenic control DJ-1-delP GC13 for the genetic Parkinson‘s disease-patient derived iPSC line DJ-1-delP (LCSBi008-A-1)

  • Pauline Mencke,
  • Zoé Hanss,
  • Javier Jarazo,
  • François Massart,
  • Arkadiusz Rybicki,
  • Elizabet Petkovski,
  • Enrico Glaab,
  • Ibrahim Boussaad,
  • Vincenzo Bonifati,
  • Jens Christian Schwamborn,
  • Wim Mandemakers,
  • Rejko Krüger

Journal volume & issue
Vol. 62
p. 102815

Abstract

Read online

We describe the generation of an isogenic control cell line DJ-1-delP GC13 from an induced pluripotent stem cell (iPSC) line DJ-1-delP LCSBi008-A that was derived from fibroblasts obtained from a Parkinson’s disease (PD) patient. Using CRISPR/Cas9 technology, we corrected the disease causing c.471_473delGCC homozygous mutation in the PARK7 gene leading to p.158P deletion in the encoded protein DJ-1. The generated isogenic pair will be used for phenotypic analysis of PD-patient derived neurons and astrocytes.